Skip to main content
PMC home page
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Sep 29.
Published in final edited form as: Am J Ophthalmol. 2022 Aug 14;242:254. doi: 10.1016/j.ajo.2022.07.018

CORRIGENDUM TO PHASE 1B RANDOMIZED CONTROLLED STUDY OF SHORT COURSE TOPICAL RECOMBINANT HUMAN NERVE GROWTH FACTOR (RHNGF) FOR NEUROENHANCEMENT IN GLAUCOMA: SAFETY, TOLERABILITY, AND EFFICACY MEASURE OUTCOMES. AM J OPHTHALMOL 2022;234:223–234

GALA BEYKIN 1, LAUREL STELL 1, MUHAMMAD SOHAIL HALIM 1, MARIANA NUÑEZ 1, LILIA POPOVA 1, BAC T NGUYEN 1, SYLVIA L GROTH 1, AMY DENNIS 1, ZHONGQIU LI 1, MELISSA ATKINS 1, TOM KHAVARI 1, SOPHIA Y WANG 1, ROBERT CHANG 1, ANN C FISHER 1, YASIR J SEPAH 1, JEFFREY L GOLDBERG 1
PMCID: PMC9515063  NIHMSID: NIHMS1833335  PMID: 35977854

The author regrets that in the February 2022 issue, Jeffrey L. Goldberg should have been listed as first author of the above Thesis according to American Ophthalmological Society policy. The corrected author list should read as follows:

Jeffrey L. Goldberg, Gala Beykin, Laurel Stell, Muhammad Sohail Halim, Mariana Nuñez, Lilia Popova, Bac T. Nguyen, Sylvia L. Groth, Amy Dennis, Zhongqiu Li, Melissa Atkins, Tom Khavari, Sophia Y. Wang, Robert Chang, Ann C. Fisher, Yasir J. Sepah.

RESOURCES